Skip to main content

Table 1 Sociodemographic and baseline data of the patients (N = 60)

From: Real-time ultrasound-guided laryngeal mask assisted percutaneous dilatational tracheostomy versus bronchoscopy-guided percutaneous dilatational tracheostomy in critically ill patients: a randomized controlled trial

Variables

All patients (n = 60)

Bronchoscopy-guided (n = 30)

Ultrasound-guided LMA-assisted (n = 30)

P-value

Age, Y

46 [39–61]

50 [42–62]

44 [36–59]

0.21

Sex, male, n (%)

47 (78.3)

22 (73.3)

25 (83.3)

0.532

Weight, kg

79.2 [70.0–91.0]

81.2 [71.5–90.2]

75.4 [67.8–91.5]

0.482

BMI, Kg/m2

28.6 [26.4–32.3]

29.1 [26.9–31.3]

28.1 [24.8–33.5]

0.756

APACHE II score

12 [6–18]

12 [6–18]

12 [6–18]

0.911

Duration of intubation, day

10.7 ± 5.0

9.8 ± 5.3

11.7 ± 4.4

0.123

Comorbidities, n (%)

    

 Diabetes

17 (28.3)

8 (26.7)

9 (30.0)

0.774

 Chronic hypertension

20 (33.3)

6 (20.0)

14 (46.7)

0.028

 Chronic heart disease

7 (11.7)

3 (10.0)

4 (20.0)

1.00

Reasons for intubation, n (%)

    

 Acute respiratory failure

33 (55.0)

17 (56.7)

16 (53.3)

0.795

 Poor neurological status

27 (45.0)

13 (43.3)

14 (46.7)

0.795

APTT, sec

35 [30–41]

34.5 [30–42]

35 [29–41]

0.635

INR

1.0 [0.9–1.2]

1.0 [0.9–1.2]

1.0 [1.0-1.2]

0.994

  1. BMI, body mass index; APACHE, acute physiologic assessment, and chronic health evaluation; DM, diabetes mellites; APTT, activated partial thromboplastin time; INR, international normalized ratio; LMA, laryngeal mask airway. Data are expressed as mean ± SD, median [25–75 interquartile], or count (%)